![John Xu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Xu was the founder of Jemincare Therapeutics Corp., founded in 2018, and served as Chief Executive Officer from 2018 to 2019.
Dr. Xu worked at Abpro Corp.
as Senior Vice President Strategic Alliances from 2017 to 2019.
Dr. Xu earned a doctorate from Zhongshan Hospital Fudan University, a graduate degree from Chicago Medical School, and an MBA from the University of Colorado Colorado Springs.
| Società | Posizione | Fine |
|---|---|---|
Jemincare Therapeutics Corp.
 Jemincare Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company focused on clinical development of therapeutics | Amministratore Delegato | 01/10/2019 |
| ABPRO CORPORATION | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 5 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Develops antibody therapies | Health Technology |
Zhongshan Hospital Fudan University
 Zhongshan Hospital Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
 Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Colorado Springs
 University of Colorado Colorado Springs Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jemincare Therapeutics Corp.
Jemincare Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company focused on clinical development of therapeutics | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
